masahiro eriguchi

Dr. masahiro eriguchi


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
TZTuantuan V. Zhao
Tuantuan V. Zhao
YLYu Li
Yu Li
XLXiaoli Liu
Xiaoli Liu
SXShudong Xia
Shudong Xia
PSPeng Shi
Peng Shi
XSXiao Z. Shen
Xiao Z. Shen
Hypertension promotes ATP release from erythrocytes, leading to a P2X7-dependent increase in T cell–mediated immune responses.

30 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMiho Murashima
Miho Murashima
MNMasatoshi Nishimoto
Masatoshi Nishimoto
MKMaiko Kokubu
Maiko Kokubu
THTakayuki Hamano
Takayuki Hamano
MMMasaru Matsui
Masaru Matsui
KTKazuhiko Tsuruya
Kazuhiko Tsuruya
This retrospective cohort study examined the roles of inflammation in acute kidney injury (AKI). Serum albumin and C-reactive protein (CRP) were used as markers of inflammation. Adults who underwent non–cardiac surgery from 2007 to 2011 were included. Exclusion criteria were urological surgery, obstetric surgery, missing data, and pre-operative dialysis. Subjects were followed until the end of 2015 or loss to follow-up. Associations between pre–operative albumin or CRP and post-operative AKI or association between AKI and mortality were examined by logistic or Cox regression, respectively. Mediation analyses were performed using albumin and CRP as mediators. Among 4,538 subjects, 272 developed AKI. Pre-operative albumin was independently associated with AKI (odds ratio [95% confidence interval (CI)]: 0.63 [0.48–0.83]). During a median follow-up of 4.5 years, 649 died. AKI was significantly associated with mortality (hazard ratio [HR] [95% CI]: 1.58 [1.22–2.04]). Further adjustment for pre-operative albumin and CRP attenuated the association (HR [95% CI]: 1.28 [0.99–1.67]). The proportions explained by mediating effects of lnCRP and albumin were 29.3% and 39.2% and mediation effects were statistically significant. In conclusion, inflammation is a predictor of AKI and a mediator of mortality after AKI. Interventions targeting inflammation might improve outcomes of AKI.

1 September 2021 in Atherosclerosis
Verified
Journal Article
Closed access
TKTakaaki Kosugi
Takaaki Kosugi
MEmasahiro eriguchi
masahiro eriguchi
HYHisako Yoshida
Hisako Yoshida
HTHikari Tasaki
Hikari Tasaki
FFFumihiro Fukata
Fumihiro Fukata
KTKazuhiko Tsuruya
Kazuhiko Tsuruya

13 January 2022 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
MEmasahiro eriguchi
masahiro eriguchi
KTKazuhiko Tsuruya
Kazuhiko Tsuruya
MLMarcelo Lopes
Marcelo Lopes
BBBrian Bieber
Brian Bieber
KMKeith McCullough
Keith McCullough
HHHideki Hirakata
Hideki Hirakata
Aims Cardiac troponin (cTn) and B-type natriuretic peptide (BNP) are elevated in haemodialysis (HD) patients, and this elevation is associated with HD-induced myocardial stunning/myocardial strain. However, studies using data from the international Dialysis Outcomes and Practice Patterns Study (DOPPS) have shown that these cardiac biomarkers are measured in <2% of HD patients in real-world practice. This study aimed to examine whether routinely measured N-terminal pro-BNP (NT-proBNP) and cTnI (contemporary assay) are more appropriate than clinical models for reclassifying the risk of HD patients who have the highest risk of death. Methods and results Pre-dialysis levels of cTnI and NT-proBNP at study enrolment were measured in 1152 HD patients (Japan DOPPS Phase 5). The patients were prospectively followed for 3 years. Cox regression was used to test the associations of cardiac biomarkers with all-cause mortality, adjusting for potential confounders. Subgroup analyses were performed to assess potential effect modification of clinical characteristics, such as age, systolic blood pressure, HD vintage, diabetes mellitus, coronary artery disease, and a history of congestive heart failure. At baseline, 337 (29%) patients had elevated cTnI (99th percentile of a healthy population: >0.04 ng/mL) with a median (inter-quartile range) level of 0.020 (0.005–0.041) ng/mL, and 1140 (99%) patients had elevated NT-proBNP (cut-off for heart failure: >125 pg/mL) with a median level of 3658 (1689–9356) pg/mL. There were 167 deaths during a median follow-up of 2.8 (2.2–2.8) years. Higher levels of both cardiac biomarkers were incrementally associated with mortality after adjustment for potential confounders. Even after adjustment for alternative cardiac biomarkers, the overall P value for the association was 0.04 ng/mL (vs. cTnI < 0.006 ng/mL) and NT-proBNP > 8000 pg/mL (vs. NT-proBNP < 2000 pg/mL) were 2.56 (95% confidence interval: 1.37–4.81) and 1.90 (95% confidence interval: 0.95–3.79), respectively. Subgroup analyses showed that the associations of both cardiac biomarkers with mortality were generally consistent between stratified groups. Conclusions Routinely measured NT-proBNP and cTnI levels are strongly associated with mortality among prevalent HD patients. These associations remain robust, even after adjustment for alternative biomarkers, suggesting that cTnI and NT-proBNP have identical prognostic significance and may reflect different pathological aspects of cardiac abnormalities.

2 November 2024 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
TKTakaaki Kosugi
Takaaki Kosugi
MEmasahiro eriguchi
masahiro eriguchi
HYHisako Yoshida
Hisako Yoshida
HTHiroyuki Tamaki
Hiroyuki Tamaki
TUTakayuki Uemura
Takayuki Uemura
KTKazuhiko Tsuruya
Kazuhiko Tsuruya

7 February 2023 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
TUTakayuki Uemura
Takayuki Uemura
MNMasatoshi Nishimoto
Masatoshi Nishimoto
MEmasahiro eriguchi
masahiro eriguchi
HTHiroyuki Tamaki
Hiroyuki Tamaki
HTHikari Tasaki
Hikari Tasaki
KTKazuhiko Tsuruya
Kazuhiko Tsuruya